Garden Stage Limited (GSIW)

Intra-Cellular Therapies Revenue

In the fiscal year ending March 31, 2025, Garden Stage had annual revenue of $5.47M with 288.10% growth. Garden Stage had revenue of $655.95K in the half year ending September 30, 2024, a decrease of -44.42%.

• Revenue (ttm): $5.47M
• Revenue Growth: +288.10%
• P/S Ratio: 0.33
• Revenue / Employee: $420,480
• Employees: 13
• Market Cap: 8.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	5.47M	4.06M	288.10%
Mar 31, 2024	1.41M	-1.85M	-56.79%
Mar 31, 2023	3.26M	952.86K	41.31%
Mar 31, 2022	2.31M	-3.82M	-62.36%
Mar 31, 2021	6.13M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.